TrueBlue Inc.
TBI | NYSE
$9.39
+$0.45 (+5.03%)
Sep 21, 2026, 10:31 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 27, 2025 | FY 2024 Dec 28, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 24, 2022 | FY 2021 Dec 25, 2021 | FY 2020 Dec 26, 2020 |
|---|---|---|---|---|---|---|
Revenue | 1.62B | 1.57B | 1.91B | 2.25B | 2.17B | 1.85B |
Cost of Revenue | 1.27B | 1.16B | 1.4B | 1.65B | 1.61B | 1.41B |
Gross Profit | 343.02M | 406.39M | 506.06M | 602.14M | 560.32M | 440.65M |
Operating Income | -26.8M | -92.78M | -23.85M | 72.19M | 68.44M | -174.88M |
Interest Income | n/a | n/a | n/a | 1.23M | n/a | 1.62M |
Pretax Income | -45.63M | -88.52M | -20.65M | 73.42M | 73.85M | -173.26M |
Net Income | -47.96M | -125.75M | -14.17M | 62.27M | 61.63M | -141.84M |
Selling & General & Admin | 371.09M | 410.87M | 494.6M | 500.69M | 464.32M | 408.31M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | 88.3M | 35.31M | 29.27M | 27.56M | 207.22M |
Operating Expenses | 371.09M | 499.17M | 529.91M | 529.96M | 491.88M | 615.53M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | 12.5M | n/a | n/a |
Cost & Expenses | 1.64B | 1.66B | 1.93B | 2.18B | 2.11B | 2.02B |
Income Tax Expense | 2.33M | 37.22M | -6.47M | 11.14M | 12.22M | -31.42M |
Shares Outstanding (Basic) | 29.85M | 30.18M | 31.32M | 32.89M | 34.8M | 35.37M |
Shares Outstanding (Diluted) | 29.85M | 30.18M | 31.32M | 33.45M | 35.43M | 35.37M |
EPS (Basic) | -1.61 | -4.17 | -0.45 | 1.89 | 1.77 | -4.01 |
EPS (Diluted) | -1.61 | -4.17 | -0.45 | 1.86 | 1.74 | -4.01 |
EBITDA | -16.78M | -3.54M | 11.46M | 115.61M | 101.41M | 32.34M |
EBIT | -45.63M | -33.1M | -14.37M | 73.42M | 73.85M | 307K |
Depreciation & Amortization | 28.85M | 29.56M | 25.82M | 42.19M | 27.56M | 32.03M |
Add to Watchlist
Select watchlists to add or remove TBI